The Journal of Pharmaceutical Policy and Practice is the official journal of the Commonwealth Pharmacists Association.
Articles
Page 3 of 16
-
Citation: Journal of Pharmaceutical Policy and Practice 2023 16:65
-
Specialized competency framework for pharmacists in managerial positions in sales and marketing (SCF-PMSM): development, validation, and correlates
Pharmacists in sales and marketing roles need specific skills for managerial positions, and a framework for evaluating and developing these competencies is necessary. Currently, no such framework is known to e...
Citation: Journal of Pharmaceutical Policy and Practice 2023 16:64 -
Expiry of veterinary medicines in supply outlets in Central Uganda: prevalence, management and associated factors
Animal diseases are a danger to livestock, businesses, and public health. This is why the public and private sectors in Africa have invested immensely in the manufacture and distribution of veterinary drugs. H...
Citation: Journal of Pharmaceutical Policy and Practice 2023 16:63 -
Antibiotic utilization pattern in treatment of acute diarrheal diseases: the case of Hiwot Fana Specialized University Hospital, Harar, Ethiopia
The vast majority of acute diarrheal diseases are self-limiting and do not require treatment on a regular basis. Empirical antibiotics should only be used to treat dysenteric and invasive bacterial diarrhea. A...
Citation: Journal of Pharmaceutical Policy and Practice 2023 16:62 -
Policy developer’s perceptions on the implementation of National Health Insurance in South Africa: a qualitative study
Universal health coverage has gained significant momentum internationally as the policy solution to address healthcare system deficiencies and promote equitable distribution of quality healthcare. The South Af...
Citation: Journal of Pharmaceutical Policy and Practice 2023 16:61 -
Contracting retail pharmacies as a source of essential medicines for public sector clients in low- and middle-income countries: a scoping review of key considerations, challenges, and opportunities
Insurances in high-income countries (HIC) often contract with private community pharmacies to dispense medicines to outpatients. In contrast, dispensing of medicines in low- and middle-income countries (LMICs)...
Citation: Journal of Pharmaceutical Policy and Practice 2023 16:60 -
Treatment and disposal practices of pharmaceutical effluent containing potential antibiotic residues in two states in India and perceptions of various stakeholders on contribution of pharmaceutical effluent to antimicrobial resistance: a qualitative study
Antimicrobial resistance (AMR) is a looming pandemic, demanding prompt actions to avert catastrophic consequences. Effluents from pharmaceutical industries containing antimicrobial residues could serve as one ...
Citation: Journal of Pharmaceutical Policy and Practice 2023 16:59 -
Patients’ views and experiences on the use and safety of directly acting oral anticoagulants: a qualitative study
Direct oral anticoagulants (DOACs) are considered high-risk medications and used to prevent thromboembolic events and stroke. This study aimed to examine patients’ views and experiences of DOACs use and factor...
Citation: Journal of Pharmaceutical Policy and Practice 2023 16:58 -
Access to a novel first-line single-tablet HIV antiretroviral regimen in Affordable Care Act Marketplace plans, 2018–2020
A pillar of the United States’ Ending the HIV Epidemic (EHE) initiative is to rapidly provide antiretroviral therapy (ART) in order to achieve HIV viral suppression. However, insurance benefit design can imped...
Citation: Journal of Pharmaceutical Policy and Practice 2023 16:57 -
The impact of educational interventional session on healthcare providers knowledge about pharmacovigilance at a tertiary Jordanian teaching hospital
A limited number of educational interventions among health care providers and students have been made in Jordan concerning the pharmacovigilance. Therefore, the main aim of this study was to evaluate how an ed...
Citation: Journal of Pharmaceutical Policy and Practice 2023 16:56 -
Vaccine cold chain management practice and associated factors among health professionals in Ethiopia: systematic review and meta-analysis
Administration of potent vaccine in a manner of well-maintained cold chain system is one of the public health focus areas in developing regions of the world. Health professionals’ adherence towards good vaccin...
Citation: Journal of Pharmaceutical Policy and Practice 2023 16:55 -
Attitudes and concerns regarding booster dose of COVID-19 vaccine among Egyptian patients with autoimmune and rheumatic diseases: a cross-sectional survey study
COVID-19 booster dose vaccination acceptance and actual vaccination behavior is not known among Egyptian individuals with autoimmune and rheumatic diseases (ARDs). The aim of this study was to investigate the ...
Citation: Journal of Pharmaceutical Policy and Practice 2023 16:54 -
The role of drug regulatory authorities and health technology assessment agencies in shaping incentives for antibiotic R&D: a qualitative study
Few antibiotics have entered the market in recent years despite the need for new treatment options. Some of the challenges of bringing new antibiotics to market are linked to the marketing authorization and he...
Citation: Journal of Pharmaceutical Policy and Practice 2023 16:53 -
Medication use review: does it have a future and potential in Latvia? The opinion of pharmacists after the pilot project
Given that the Medication Use Review (MUR) can be used as a tool to improve the quality, safety, and appropriate use of medications, it has been implemented in several countries around the world. The MUR pilot...
Citation: Journal of Pharmaceutical Policy and Practice 2023 16:52 -
The impact of the increase in import verification fees on local production capacity of selected medicines in Uganda
The local manufacture of pharmaceuticals is an opportunity to develop a broader manufacturing and knowledge-based economy and reduce over dependence on imports. To promote local production, the Ugandan governm...
Citation: Journal of Pharmaceutical Policy and Practice 2023 16:51 -
Continuity of CVD treatment during the COVID-19 pandemic: evidence from East Java, Indonesia
In Indonesia, the world's fourth most populous country, cardiovascular diseases (CVDs) are a leading cause of death and disability. Government efforts to reduce the burden of CVD include a community-based prev...
Citation: Journal of Pharmaceutical Policy and Practice 2023 16:50 -
Interprofessional collaboration within general practice teams following the inclusion of non-dispensing pharmacists
Pharmacists have been included in general practice teams to provide non-dispensing services in the Australian Capital Territory (ACT) since 2016. Interprofessional collaboration and team effectiveness are key ...
Citation: Journal of Pharmaceutical Policy and Practice 2023 16:49 -
The association of management and leadership competencies with work satisfaction among pharmacists in Lebanon
Pharmacists are at the core of the healthcare system and are the most accessible healthcare professionals. Their new roles involve leadership skills, among others. Work satisfaction of pharmacists might affect...
Citation: Journal of Pharmaceutical Policy and Practice 2023 16:48 -
Evaluating self-medication practices in Ethiopia
Self-medication with antibiotics has become an important factor driving antibiotic resistance and it masks the signs and symptoms of the underlying disease and hence complicates the problem, increasing drug re...
Citation: Journal of Pharmaceutical Policy and Practice 2023 16:47 -
Awareness, practices and perceptions of community pharmacists towards antimicrobial resistance and antimicrobial stewardship in Libya: a cross-sectional study
Community pharmacists play a vital role in promoting appropriate use of antibiotics in the community. This study evaluated the practices and perceptions of community pharmacists towards antibiotic use, antibio...
Citation: Journal of Pharmaceutical Policy and Practice 2023 16:46 -
Qualitative exploration of perspectives of the pharmacists working in public-sector hospitals during COVID-19 pandemic
The COVID-19 pandemic, a serious global health threat, has excruciating social and economic implications given its transmissibility, lack of therapy, and severity. In such a situation, pharmacists as frontline...
Citation: Journal of Pharmaceutical Policy and Practice 2023 16:45 -
Medicine shortages: impact behind numbers
Current research to assess the impact that medicine shortages have on patients is limited to general aspects, such as the prevalence of shortages and product characteristics. The aim of this study is to assess...
Citation: Journal of Pharmaceutical Policy and Practice 2023 16:44 -
Improving the quality of publications in and advancing the paradigms of clinical and social pharmacy practice research: The Granada statements
Pharmacy and pharmaceutical sciences embrace a series of different disciplines. Pharmacy practice has been defined as “the scientific discipline that studies the different aspects of the practice of pharmacy a...
Citation: Journal of Pharmaceutical Policy and Practice 2023 16:43 -
COVID-19 and diabetes in 2020: a systematic review
Attempts were made to review the literature on diabetic patients who experience complications when they contract COVID-19, and to determine whether ethnicity and other risk factors play an important role in th...
Citation: Journal of Pharmaceutical Policy and Practice 2023 16:42 -
Knowledge and attitudes toward euthanasia among final year pharmacy and law students: a cross-sectional study
Euthanasia is the last resort for those living with untreatable and terminable diseases which cause pain and suffering. However, the concept of euthanasia resulted in many dilemmas and controversy around life ...
Citation: Journal of Pharmaceutical Policy and Practice 2023 16:41 -
The pharmacist as safety net: an interview-based study of the intersecting dependencies between doctors and pharmacists
Social science research has demonstrated how health practitioners negotiate and contest professional roles and jurisdictions in practice, and in ways that reflect the power dynamics that permeate medicine. Thi...
Citation: Journal of Pharmaceutical Policy and Practice 2023 16:40 -
When a neglected tropical zoonotic disease emerges in non-endemic countries: need to proactively fill the unveiled knowledge gaps towards human monkeypox among the Lebanese population
The ongoing multi-country outbreak of monkeypox (MPX) that emerges in non-endemic areas is a rare and unprecedented event that has sparked a widespread public health concern. Lebanon has reported four confirme...
Citation: Journal of Pharmaceutical Policy and Practice 2023 16:39 -
Secondary bacterial infection caused by ST16 NDM-1 and OXA-48-producing colistin and carbapenem-resistant Klebsiella pneumoniae treated with tigecycline in a pregnant woman with COVID-19
During the COVID-19 pandemic, the rapid emergence of carbapenem and colistin-resistant Klebsiella pneumoniae has resulted in an alarming situation worldwide. We aimed to describe secondary infections and antimicr...
Citation: Journal of Pharmaceutical Policy and Practice 2023 16:38 -
Attitudes, awareness, and perceptions of general public and pharmacists toward the extended community pharmacy services and drive-thru pharmacy services: a systematic review
Several extended and newly added pharmacy services were evaluated in different countries. This review aims to provide a summary of studies on attitudes, awareness, or perceptions toward various extended and dr...
Citation: Journal of Pharmaceutical Policy and Practice 2023 16:37 -
Hospital pharmacy response to the COVID-19 pandemic: experience from a regional referral center in the United Arab Emirates
The recent SARS‐CoV‐2 pandemic has resulted in significant morbidity and mortality worldwide. The healthcare systems, including pharmacies, faced unique challenges, such as managing an overwhelming patient in...
Citation: Journal of Pharmaceutical Policy and Practice 2023 16:36 -
Impact of COVID-19 pandemic on the availability of maternal and child health products and childhood vaccines
In many low- and middle-income countries, the 2019 novel coronavirus (COVID-19) has challenged efforts to ensure access to and availability of quality maternal, newborn, and child health (MCH) services and ess...
Citation: Journal of Pharmaceutical Policy and Practice 2023 16:35 -
Regulatory registration timelines of generic medicines in South Africa: Assessment of the performance of SAHPRA between 2011 and 2022
Various regulatory authorities are experiencing backlogs of applications which result in delayed access to medicines for patients. The objective of this study is to critically assess the registration process u...
Citation: Journal of Pharmaceutical Policy and Practice 2023 16:34 -
Scoping of pharmacists’ health leadership training needs for effective antimicrobial stewardship in Africa
Antimicrobial resistance (AMR) is a global public health concern currently mitigated by antimicrobial stewardship (AMS). Pharmacists are strategically placed to lead AMS actions that contribute to responsible ...
Citation: Journal of Pharmaceutical Policy and Practice 2023 16:33 -
Compliance of public health facilities with essential medicines and health supplies redistribution guidelines in Mbale district, Eastern Uganda: a mixed-methods study
Redistribution of essential medicines and health supplies (EMHS) is a mechanism to address supply chain uncertainty by moving excess stock of health commodities from health facilities that are overstocked to h...
Citation: Journal of Pharmaceutical Policy and Practice 2023 16:32 -
Assessment of medicines cold chain storage conformity with the requirements of the World Health Organization in health facilities of the Eastern Province of Rwanda
Despite the prominent evidence of cold chain monitoring in the health system to reduce wastage and maintain product potency, there are still inefficiencies in the storage and transportation of cold chain produ...
Citation: Journal of Pharmaceutical Policy and Practice 2023 16:31 -
Analysis of pharmaceutical inventory management based on ABC-VEN analysis in Rwanda: a case study of Nyamagabe district
Pharmaceuticals account for a large portion of healthcare spending in healthcare organizations. Their effective inventory management is required to match the cost of stocks with the customer demand and avoid s...
Citation: Journal of Pharmaceutical Policy and Practice 2023 16:30 -
Telepharmacy during home isolation: drug-related problems and pharmaceutical care in COVID-19 patients receiving antiviral therapy in Thailand
Home isolation has been proposed for coronavirus disease 2019 (COVID-19) patients with mild symptoms to avoid hospital overcrowding. This study aimed to describe the drug-related problems (DRPs) and the pharma...
Citation: Journal of Pharmaceutical Policy and Practice 2023 16:29 -
Extent of cardiovascular medications dispensing practice without a prescription: Self-reported and simulated patient-based study at community pharmacies in Northwest Ethiopia
Critical actions are required for the proper administration of medications to patients with cardiovascular diseases. However, there has been an increase in irrational use of cardiovascular drugs. The purpose o...
Citation: Journal of Pharmaceutical Policy and Practice 2023 16:28 -
Promoting generic drug usage in Japan: correlation between generic drug usage and monthly personal income
To reduce pharmacy-related medical expenses, it is necessary to cut drug costs, potentially by increasing generic drug usage. This study analyzes the correlation between generic drug usage and monthly personal...
Citation: Journal of Pharmaceutical Policy and Practice 2023 16:27 -
Barriers and facilitators to implementing simulation into pharmacy programs globally
MyDispense is a simulation software developed by Monash University that has been utilized by over 200 institutions worldwide to educate pharmacy students. However, little is known about the processes by which ...
Citation: Journal of Pharmaceutical Policy and Practice 2023 16:26 -
Evaluation of vaccine storage and distribution practices in rural healthcare facilities in Kenya
Vaccines require cold chain storage conditions, and good distribution practices throughout the supply chain to maintain their quality and potency. However, in the last mile of the vaccines supply chain, these ...
Citation: Journal of Pharmaceutical Policy and Practice 2023 16:25 -
A 1-year analysis of adverse events following COVID-19 vaccination in Lebanon: a retrospective study
Since the deployment of Coronavirus Disease 2019 (COVID-19) vaccines, skepticism about the safety, incidence, and severity of Adverse Events Following Immunization (AEFI) was a concern. The study has two main ...
Citation: Journal of Pharmaceutical Policy and Practice 2023 16:24 -
Antibiotics prescribing practice among patients with urinary tract infection at outpatient department, the case of Dilchora referral hospital, Eastern Ethiopia: an institutional retrospective cross-sectional study
Inappropriate prescription of antibiotics is a global public health challenge. Widespread use, misuse, or inappropriate prescribing has resulted in unnecessary expenditure on drugs, raised risk of adverse reac...
Citation: Journal of Pharmaceutical Policy and Practice 2023 16:23 -
The reimbursement process in three national healthcare systems: variation in time to reimbursement of pembrolizumab for metastatic non-small cell lung cancer
In this article, we focus on the reimbursement process, and as an example, characterize the time to reimbursement of pembrolizumab, a PD-1 immune checkpoint inhibitor for treatment of metastatic NSCLC from public...
Citation: Journal of Pharmaceutical Policy and Practice 2023 16:22 -
Public–private partnership alternative for a national pharmacare program in Canada
Recently, the government and an opposition party cut a deal that involved a promise to consider implementing a single-payer pharmacare scheme in Canada in exchange for supporting the current minority governmen...
Citation: Journal of Pharmaceutical Policy and Practice 2023 16:21 -
Hypertension self-care practice and its associated factors in Bale Zone, Southeast Ethiopia: A multi-center cross-sectional study
Hypertension is a serious threat to public health globally owing to its high prevalence and related complications. It is the main risk factor for cardiovascular disease, kidney disease, eye problems, and death...
Citation: Journal of Pharmaceutical Policy and Practice 2023 16:20 -
A quantitative classification of OTC medicines regulations in 30 European countries: dispensing restrictions, distribution, pharmacy ownership, and pricing systems
This paper reviews the regulations of over-the-counter (OTC) medicines in 30 European countries with the goal of identifying the regulatory trends and clusters as of May 2022.
Citation: Journal of Pharmaceutical Policy and Practice 2023 16:19 -
Bridging the gap? Local production of medicines on the national essential medicine lists of Kenya, Tanzania and Uganda
Essential medicines (EMs) are those that satisfy the basic healthcare needs of the population. However, access to EMs remains a global health challenge. The World Health Organization (WHO) and the East African...
Citation: Journal of Pharmaceutical Policy and Practice 2023 16:18 -
Community pharmacists’ perceptions and experiences of stress during COVID-19
Pharmacists play a crucial role in the COVID-19 pandemic scenario, performing frontline roles for the community, and supporting the healthcare system. This study aimed at investigating stress and its correlate...
Citation: Journal of Pharmaceutical Policy and Practice 2023 16:17 -
Community physicians’ attitudes towards meetings with representatives of pharmaceutical companies: a pilot study
Marketing by pharmaceutical companies has become an increasingly controversial issue for the medical community and the public. This controversy stems from the potential influence that pharmaceutical companies ...
Citation: Journal of Pharmaceutical Policy and Practice 2023 16:15
Follow
Annual Journal Metrics
-
2022 Citation Impact
4.2 - 2-year Impact Factor
1.266 - SNIP (Source Normalized Impact per Paper)
0.574 - SJR (SCImago Journal Rank)2022 Speed
9 days submission to first editorial decision for all manuscripts (Median)
97 days submission to accept (Median)2022 Usage
708,141 downloads
5,255 Altmetric mentions